EPH255 Healthcare Resource Consumption of Patients with Cardiovascular Events after Exacerbations of Chronic Obstructive Pulmonary Disease in Italy: Results from the EXACOS-CV Study

Silvia Calabria; Giulia Ronconi; Letizia Dondi; Letizia Dondi; Irene Dell’Anno; Clémentine Nordon; Kirsty Rhodes; Krishnali Parsekar; N. Martini; Aldo Maggioni

doi:10.1016/j.jval.2023.09.1296

EPH255 Healthcare Resource Consumption of Patients with Cardiovascular Events after Exacerbations of Chronic Obstructive Pulmonary Disease in Italy: Results from the EXACOS-CV Study — Silvia Calabria (2023) | RDL Network

Back

Home
Publications
EPH255 Healthcare Resource Consumption of Patients with Cardiovascular Events after Exacerbations of Chronic Obstructive Pulmonary Disease in Italy: Results from the EXACOS-CV Study

Shared by

Aldo Maggioni

EPH255 Healthcare Resource Consumption of Patients with Cardiovascular Events after Exacerbations of Chronic Obstructive Pulmonary Disease in Italy: Results from the EXACOS-CV Study

Article 2023 en

Authors

SC
Silvia Calabria
GR
Giulia Ronconi
LD
Letizia Dondi

Discussion(0)

No comments yet. Be the first to comment.

Publication Info

DOI: 10.1016/j.jval.2023.09.1296
Year: 2023
Published: —
Language: en

Article Details

Volume: 26
Issue: 12
Link Of The Paper: https://doi.org/10.1016/j.jval.2023.09.1296

Timeline

Related publications

Article2024

Cardiovascular events after exacerbations of chronic obstructive pulmonary disease: Results from the EXAcerbations of COPD and their OutcomeS in CardioVascular diseases study in Italy

Silvia Calabria, Giulia Ronconi, Letizia Dondi, Leonardo Dondi, Irene Dell’Anno, Clémentine Nordon, Kirsty Rhodes, Paola Rogliani, Francesco Dentali, Nello Martini, Aldo Maggioni

Letter2024

Risk of Cardiovascular Events after Acute Exacerbations of Chronic Obstructive Pulmonary Disease in Patients Receiving Long-Term Low-Dose Azithromycin

Tommaso Bucci, Dennis Wat, D. Nazareth, Sarah Sibley, Dan Wootton, Professor Gregory Lip, Freddy Frost

Article2007

Exacerbations of chronic obstructive pulmonary disease

Bartolomé R. Celli, Peter J Barnes

Article2023

Does azithromycin modulate cardiovascular risk following acute pulmonary exacerbations of chronic obstructive pulmonary disease?

Freddy Frost, Tomasso Bucci, Dennis Wat, Sarah Sibley, David Green, Professor Gregory Lip

Article2009

New drugs for exacerbations of chronic obstructive pulmonary disease

Trevor T. Hansel, Peter J Barnes

Created:

June 19, 2026